<DOC>
	<DOCNO>NCT01635010</DOCNO>
	<brief_summary>Obstructive Sleep Apnea ( OSA ) commonly associate factor increase cardiovascular risk , include Metabolic Syndrome ( MS ) . There lack well-controlled clinical study investigate independent effect OSA development cardiovascular disease , especially evaluate jointly mechanism involve disorder inflammatory response , oxidative stress vascular change . The investigator hypothesize absence MetS , mechanisms involved cardiovascular consequence OSA patient would less important . The purpose study analyze effect OSA absence MS , inflammatory , oxidative stress vascular marker ; verify influence excessive daytime sleepiness ( EDS ) parameter ; additionally verify effect nasal continuous positive airway pressure ( nCPAP ) theses parameter .</brief_summary>
	<brief_title>Obstructive Sleep Apnea Absence Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>male subject apneahypopnea index &gt; 15/h ( OSA group ) apneahypopnea index &lt; 5/h ( control group ) body mass index ( BMI ) &gt; 30 kg/m2 age &gt; 60 year chronic obstructive pulmonary disease cardiac diseases diabetes mellitus metabolic syndrome accord modify National Cholesterol Education Program Adult Treatment Panel III criterion previous OSA treatment</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>obstructive sleep apnea</keyword>
	<keyword>inflammation</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>arterial stiffness</keyword>
</DOC>